A Potential Parkinson’s Treatment Has Promising Results
Jun 20, 2024 · A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based...
New Parkinson’s drug could slow or reverse progression of disease ...
Aug 21, 2024 · New Parkinson’s drug could slow or reverse progression of disease, researchers say: ‘Big step forward’. Published On. August 21, 2024. Social Media. Share this article. “People with Parkinson’s should be aware that although the findings were interesting, this was only a safety, tolerability and immunogenicity study, and thus there is ...
Parkinson's News Today Home | Parkinson's News Today
3 days ago · Phase 2 trial of bezisterim in newly diagnosed patients to start soon. The planned Phase 2 SUNRISE-PD clinical trial of oral bezisterim as a first-line, stand-alone treatment for newly diagnosed Parkinson’s disease patients is scheduled to begin in early 2025.
FDA Approves New Treatment for Advanced Parkinson’s Disease
Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help...
New Parkinson’s Treatments in the Clinical Trial Pipeline for 2024
Sep 26, 2023 · Extensive research is underway to develop new medications for Parkinson's disease (PD), with several promising candidates at different stages of development.
New tech could improve care for Parkinson’s patients
Sep 23, 2024 · Now, Stanford Medicine researchers have developed a simple, portable device paired with a smartphone-connected platform that patients can use at home to measure the severity of their Parkinson’s ...
New Findings About Key Pathological Protein in Parkinson’s Disease …
Dec 18, 2023 · A so-called pathological protein long associated with Parkinson’s disease has been found in a new study to trigger cells to increase protein synthesis, an event that eventually kills the subset of brain cells that die off in this neurodegenerative condition.
Protein variant presents a potential new target for developing ...
3 days ago · Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future may serve as a target for developing new treatments for this terrible ...
New Vaccine for Parkinson’s Moves Closer to 1st Human Trials
Dec 1, 2022 · An experimental vaccine that stimulates immune responses against three regions of the alpha-synuclein protein — whose toxic clumps contribute to Parkinson’s disease and dementia with Lewy bodies (DLB) — is moving into late-stage preclinical research aimed at supporting future requests to test it in clinical trials.
Risvodetinib may slow Parkinson's progression, clinical trial...
Mar 11, 2024 · Risvodetinib, an oral therapy being developed by Inhibikase Therapeutics for Parkinson’s disease, appears to stabilize disease status and severity, according to data covering 25 patients who finished 12 weeks of dosing in an ongoing Phase 2 clinical trial.